A detailed history of Cbiz Investment Advisory Services, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cbiz Investment Advisory Services, LLC holds 51 shares of BIIB stock, worth $8,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51
Previous 23 121.74%
Holding current value
$8,545
Previous $2,000 250.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$122.68 - $148.84 $3,435 - $4,167
28 Added 121.74%
51 $7,000
Q2 2025

Aug 11, 2025

BUY
$113.38 - $135.49 $1,814 - $2,167
16 Added 228.57%
23 $2,000
Q4 2024

Feb 10, 2025

BUY
$146.47 - $191.55 $1,025 - $1,340
7 New
7 $1,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $24.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cbiz Investment Advisory Services, LLC Portfolio

Follow Cbiz Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cbiz Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cbiz Investment Advisory Services, LLC with notifications on news.